ArticleTherapeutic innovation & regulatory science2025

Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan.

Minako Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.